Julia Lainster

A pivotal study in precision oncology is poised to reshape how clinicians approach cancers driven by specific genetic alterations, offering a detailed roadmap for identifying and treating mutations that have long been underrecognized. Led by Dr. Wei Yang and his team, the research introduces a

A groundbreaking study has unveiled a novel method for detecting Parkinson's disease through a simple blood test, potentially years before the onset of debilitating physical symptoms. This pivotal discovery, emerging from a collaboration between researchers at Chalmers University of Technology in

Researchers have developed a groundbreaking microfluidic chip using a single-step 3D printing process that successfully mimics the three-dimensional environments where cells grow in the human body, a development poised to revolutionize how diseases are studied and new drugs are tested. This new

With deep expertise in biopharmaceutical research and a keen eye on the technological revolution shaping healthcare, Ivan Kairatov joins us to dissect the rapid rise of ambient AI scribes. We’ll explore the nuanced impact of this technology, moving beyond the initial excitement to discuss how it’s

For individuals living with debilitating genetic skin disorders, effective treatments have remained elusive, often limited to managing symptoms rather than addressing the root cause encoded in their DNA. A groundbreaking development from researchers at the University of British Columbia and the

The most advanced medical treatments of our time, including powerful gene and cell therapies, often present a formidable paradox: their immense power to heal is matched by their potential for uncontrolled and harmful side effects. This challenge has driven a quest for a new level of precision, a

A new wave of philanthropic investment is poised to transform how society supports individuals facing the end of life, moving beyond the traditional focus on managing physical pain to directly address the profound emotional and existential suffering that often accompanies a terminal diagnosis. This

A fundamental shift is underway in the landscape of oncology, where the promise of precision medicine is rapidly becoming a clinical reality, moving treatment from generalized protocols to strategies tailored to an individual’s unique genetic makeup. A pivotal research effort has culminated in the

Sophisticated nanodelivery systems that respond to multiple biological cues are rapidly redefining the landscape of targeted therapeutics, offering a highly precise method for overcoming the formidable barriers presented by diseases like metastatic cancer. This review explores the evolution of

With us today is Ivan Kairatov, a biopharma expert with deep experience in research and development, to discuss the evolving story of Sarepta’s gene therapy, Elevidys. We’ll explore how new long-term data is reshaping the clinical conversation around the therapy’s effectiveness, the commercial